Cystatin C, Left Ventricular Hypertrophy, and Diastolic Dysfunction: Data From the Heart and Soul Study
- 31 October 2006
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 12 (8) , 601-607
- https://doi.org/10.1016/j.cardfail.2006.07.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul StudyThe American Journal of Cardiology, 2005
- Cystatin-C and mortality in elderly persons with heart failureJournal of the American College of Cardiology, 2005
- Left Ventricular Diastolic Dysfunction and Diastolic Heart FailureAnnual Review of Medicine, 2004
- B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary DiseaseCirculation, 2003
- Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the CommunityCirculation, 2003
- Serum Cystatin C Concentration as a Marker of Renal Dysfunction in the ElderlyAmerican Journal of Kidney Diseases, 2001
- Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II SystemScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Markers for cardic damage - current status and future trends 7th Bergmeyer Conference. IFCC-Roche Diagnostics Master Discussion Improving the Clinical Value of Laboratory DataScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: Correlation with autopsy and M-mode echocardiographyJournal of the American Society of Echocardiography, 1996
- Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinineKidney International, 1995